Breakthrough 'take-at-home' prostate cancer drug gets green light for NHS use, sparing patients from lengthy hospital visits throwing a lifeline to 40,000 men
newsare.net
Relugolix has been given the go-ahead on the NHS, potentially helping 40,000 men with advanced hormone sensitive prostate cancer.Breakthrough 'take-at-home' prostate cancer drug gets green light for NHS use, sparing patients from lengthy hospital visits throwing a lifeline to 40,000 men
Relugolix has been given the go-ahead on the NHS, potentially helping 40,000 men with advanced hormone sensitive prostate cancer. Read more